Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 8/20 | 0.52 |
| ▸ | RAB9A | P51151 | 8/20 | 0.52 |
| ▸ | RET | P07949 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.40 |
| ▸ | POLB | P06746 | 2/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | EGFR | P00533 | 1/20 | 0.39 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1423179 | 0.89 | NPC1 (0.64) | NPC1RAB9ASMN1; SMN2TP53GAA | |
| Trifluoroacetic Acid SCHEMBL4928621 | 0.86 | NPC1 (0.57) | NPC1RAB9ARETSMN1; SMN2TP53 | |
| Trifluoroacetic Acid SCHEMBL4927507 | 0.85 | NPC1 (0.57) | NPC1RAB9ASMN1; SMN2TP53KDM4E | |
| Trifluoroacetic Acid SCHEMBL3627745 | 0.85 | NPC1 (0.55) | NPC1RAB9ARETSMN1; SMN2TP53 | |
| Trifluoroacetic Acid SCHEMBL3631223 | 0.85 | NPC1 (0.58) | NPC1RAB9ARETSMN1; SMN2TP53 | |
| Trifluoroacetic Acid SCHEMBL3627828 | 0.84 | KDM4E (0.50) | NPC1RAB9ASMN1; SMN2TP53GAA | |
| Trifluoroacetic Acid SCHEMBL4920951 | 0.83 | NPC1 (0.76) | NPC1RAB9ASMN1; SMN2TP53GAA | |
| Trifluoroacetic Acid SCHEMBL3633170 | 0.81 | NPC1 (0.54) | NPC1RAB9ASMN1; SMN2KDM4EL3MBTL1 | |
| Trifluoroacetic Acid SCHEMBL4919398 | 0.80 | NPC1 (0.60) | NPC1RAB9ASMN1; SMN2TP53GAA | |
| Trifluoroacetic Acid SCHEMBL4929367 | 0.77 | KDM4E (0.57) | NPC1RAB9ASMN1; SMN2TP53KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080255203-A1 | HETEROCYCLIC COMPOUNDS AND THEIR METHODS OF USE | ABBOTT LABORATORIES (US) | 2008-10-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080255203-A1 | HETEROCYCLIC COMPOUNDS AND THEIR METHODS OF USE | CYP11B2, AADAC, CYP11B1 | NPC1 473/4885RAB9A 3859/4885RET 3570/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.